Nath Bio-Genes (India) 過去の業績
過去 基準チェック /26
Nath Bio-Genes (India)の収益は年間平均-14.6%の割合で減少していますが、 Food業界の収益は年間 増加しています。収益は年間15% 3.4%割合で 増加しています。 Nath Bio-Genes (India)の自己資本利益率は6.2%であり、純利益率は11.2%です。
主要情報
-14.6%
収益成長率
-14.6%
EPS成長率
| Food 業界の成長 | 17.6% |
| 収益成長率 | 3.4% |
| 株主資本利益率 | 6.2% |
| ネット・マージン | 11.2% |
| 前回の決算情報 | 30 Sep 2024 |
最近の業績更新
Recent updates
Here's Why Shareholders Should Examine Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) CEO Compensation Package More Closely
Aug 11
Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Solid Earnings May Rest On Weak Foundations
Jul 31Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Shares Fly 34% But Investors Aren't Buying For Growth
Jul 02These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Jun 27Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has More To Do To Multiply In Value Going Forward
Apr 05Returns On Capital At Nath Bio-Genes (India) (NSE:NATHBIOGEN) Have Hit The Brakes
Oct 24Nath Bio-Genes (India) (NSE:NATHBIOGEN) Seems To Use Debt Quite Sensibly
Aug 05Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has Some Way To Go To Become A Multi-Bagger
Jun 07Some Investors May Be Worried About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Feb 11We Think Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Taking Some Risk With Its Debt
Aug 27Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital Not Reflecting Well On The Business
Jun 19Nath Bio-Genes (India) (NSE:NATHBIOGEN) Has A Pretty Healthy Balance Sheet
Feb 24Returns On Capital Signal Tricky Times Ahead For Nath Bio-Genes (India) (NSE:NATHBIOGEN)
May 27Is Nath Bio-Genes (India) (NSE:NATHBIOGEN) A Risky Investment?
Feb 28The Trends At Nath Bio-Genes (India) (NSE:NATHBIOGEN) That You Should Know About
Feb 07Declining Stock and Decent Financials: Is The Market Wrong About Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)?
Jan 19The Nath Bio-Genes (India) (NSE:NATHBIOGEN) Share Price Is Up 149% And Shareholders Are Boasting About It
Jan 01Why Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay Matters
Dec 14
These 4 Measures Indicate That Nath Bio-Genes (India) (NSE:NATHBIOGEN) Is Using Debt Reasonably Well
Nov 26Here's What To Make Of Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) Returns On Capital
Nov 05Do Its Financials Have Any Role To Play In Driving Nath Bio-Genes (India) Limited's (NSE:NATHBIOGEN) Stock Up Recently?
Oct 15Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Might Not Be As Mispriced As It Looks After Plunging 25%
Sep 24Many Still Looking Away From Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
Sep 08Introducing Nath Bio-Genes (India) (NSE:NATHBIOGEN), The Stock That Soared 311% In The Last Five Years
Sep 07Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN) Doing What It Can To Lift Shares
Aug 18Here's What We Think About Nath Bio-Genes (India)'s (NSE:NATHBIOGEN) CEO Pay
Jul 26収支内訳
収支内訳
Nath Bio-Genes (India) の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Sep 24 | 3,510 | 394 | 535 | 0 |
| 30 Jun 24 | 3,414 | 398 | 509 | 0 |
| 31 Mar 24 | 3,328 | 396 | 442 | 0 |
| 31 Dec 23 | 3,346 | 374 | 440 | 0 |
| 30 Sep 23 | 3,281 | 379 | 425 | 0 |
| 30 Jun 23 | 3,273 | 374 | 421 | 0 |
| 31 Mar 23 | 3,014 | 350 | 372 | 0 |
| 31 Dec 22 | 2,836 | -827 | 567 | 0 |
| 30 Sep 22 | 2,799 | -813 | 589 | 0 |
| 30 Jun 22 | 2,731 | -815 | 511 | 0 |
| 31 Mar 22 | 2,784 | -674 | 382 | 0 |
| 31 Dec 21 | 3,062 | 561 | 325 | 0 |
| 30 Sep 21 | 3,205 | 575 | 373 | 0 |
| 30 Jun 21 | 3,289 | 593 | 412 | 0 |
| 31 Mar 21 | 3,076 | 557 | 411 | 0 |
| 31 Dec 20 | 3,127 | 562 | 439 | 0 |
| 30 Sep 20 | 3,097 | 558 | 424 | 0 |
| 30 Jun 20 | 3,078 | 565 | 425 | 0 |
| 31 Mar 20 | 2,799 | 505 | 354 | 0 |
| 31 Dec 19 | 2,721 | 482 | 437 | 0 |
| 30 Sep 19 | 2,669 | 478 | 407 | 0 |
| 30 Jun 19 | 2,693 | 477 | 412 | 0 |
| 31 Mar 19 | 2,309 | 384 | 302 | 0 |
| 31 Dec 18 | 2,286 | 349 | 456 | 0 |
| 30 Sep 18 | 2,265 | 353 | 428 | 0 |
| 30 Jun 18 | 2,171 | 353 | 570 | 0 |
| 31 Mar 18 | 1,917 | 294 | 215 | 0 |
| 31 Dec 17 | 1,929 | 255 | 214 | 0 |
| 30 Sep 17 | 1,854 | 227 | 188 | 0 |
| 30 Jun 17 | 1,869 | 199 | 491 | 0 |
| 31 Mar 17 | 1,699 | 163 | 241 | 0 |
| 31 Dec 16 | 1,477 | 149 | 144 | 0 |
| 30 Sep 16 | 1,529 | 143 | 171 | 0 |
| 30 Jun 16 | 1,524 | 66 | 276 | 0 |
| 31 Mar 16 | 1,626 | 142 | 264 | 0 |
| 31 Dec 15 | 1,437 | -137 | 855 | 122 |
| 30 Sep 15 | 1,468 | 114 | 870 | 122 |
| 30 Jun 15 | 1,729 | 192 | 886 | 122 |
| 31 Mar 15 | 1,857 | 254 | 299 | 0 |
| 31 Mar 14 | 1,725 | 243 | 752 | 106 |
質の高い収益: NATHBIOGENは 高品質の収益 を持っています。
利益率の向上: NATHBIOGENの現在の純利益率 (11.2%)は、昨年(11.5%)よりも低くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: NATHBIOGENの収益は過去 5 年間で年間14.6%減少しました。
成長の加速: NATHBIOGENの過去 1 年間の収益成長率 ( 3.9% ) は、5 年間の平均 ( 年間-14.6%を上回っています。
収益対業界: NATHBIOGENの過去 1 年間の収益成長率 ( 3.9% ) Food業界16.8%を上回りませんでした。
株主資本利益率
高いROE: NATHBIOGENの 自己資本利益率 ( 6.2% ) は 低い とみなされます。